{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T13:57:03Z","timestamp":1772287023385,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,24]],"date-time":"2013-06-24T00:00:00Z","timestamp":1372032000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Budd\u2013Chiari syndrome (BCS) often leads to hepatocellular carcinoma (HCC). Transcatheter arterial chemoembolization (TACE) has been increasingly used to treat BCS patients with HCC. The purposes of this study were to illustrate imaging features in BCS patients with HCC, and to analyze the effects of TACE on BCS patients with HCC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>246 consecutive patients with primary BCS were retrospectively studied. 14 BCS patients with HCC were included in this study. BCS were treated with angioplasty and\/or stenting, and HCC were managed with TACE. Imaging features on ultrasonography, CT, MRI, and angiography and the serum AFP level were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Inferior vena cava block and stricture of hepatic venous outflow tract more frequently occurred. Portal vein invasion was found in only 2 patients (14.2%). Imaging studies showed that most nodules of HCC were near the edge of liver, irregular, more than 3 cm in diameter, heterogeneous mass and solitary (\u22643 nodules). HCC in patients associated with BCS was isointense or hypointense in nonenhanced CT images, and exhibited heterogeneous enhancement during the arterial phase and washout during the portal venous phase on enhanced CT and MRI. The serum AFP level significantly declined after TACE treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>BCS patients with inferior vena cava block and stricture of hepatic venous outflow tract seems to be associated with HCC. A single, large, irregular nodule with a peripheral location appears to be HCC. TACE can effectively treat HCC in BCS patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-230x-13-105","type":"journal-article","created":{"date-parts":[[2013,6,24]],"date-time":"2013-06-24T10:14:25Z","timestamp":1372068865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Hepatocellular carcinoma associated with budd-chiari syndrome: imaging features and transcatheter arterial chemoembolization"],"prefix":"10.1186","volume":"13","author":[{"given":"Feng-Yong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Sheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,24]]},"reference":[{"key":"961_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1056\/NEJMra020282","volume":"350","author":"KV Menon","year":"2004","unstructured":"Menon KV, Shah V, Kamath PS: The budd-chiari syndrome. N Engl J Med. 2004, 350: 578-585. 10.1056\/NEJMra020282.","journal-title":"N Engl J Med"},{"key":"961_CR2","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.3748\/wjg.v13.i19.2693","volume":"13","author":"M Aydinli","year":"2007","unstructured":"Aydinli M, Bayraktar Y: Budd-chiari syndrome: etiology, pathogenesis and diagnosis. World J Gastroenterol. 2007, 13: 2693-2696.","journal-title":"World J Gastroenterol"},{"key":"961_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jhep.2008.10.007","volume":"50","author":"DC Valla","year":"2009","unstructured":"Valla DC: Primary budd-chiari syndrome. J Hepatol. 2009, 50: 195-203. 10.1016\/j.jhep.2008.10.007.","journal-title":"J Hepatol"},{"key":"961_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00042737-200403000-00012","volume":"16","author":"SH Shin","year":"2004","unstructured":"Shin SH, Chung YH, Suh DD, Shin JW, Jang MK, Ryu SH, Park NH, Lee HC, Lee YS, Suh DJ: Characteristic clinical features of hepatocellular carcinoma associated with budd-chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2004, 16: 319-324.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"961_CR5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/hep.1840380404","volume":"38","author":"DC Valla","year":"2003","unstructured":"Valla DC: The diagnosis and management of the budd-chiari syndrome: consensus and controversies. Hepatology. 2003, 38: 793-803.","journal-title":"Hepatology"},{"key":"961_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0168-8278(02)00434-8","volume":"38","author":"HL Janssen","year":"2003","unstructured":"Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC: Budd-chiari syndrome: a review by an expert panel. J Hepatol. 2003, 38: 364-371.","journal-title":"J Hepatol"},{"key":"961_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.1440-1827.1999.00856.x","volume":"49","author":"M Katoh","year":"1999","unstructured":"Katoh M, Shigematsu H: Primary liver carcinoma complicating membranous obstruction of the inferior vena cava. Pathol Int. 1999, 49: 253-257. 10.1046\/j.1440-1827.1999.00856.x.","journal-title":"Pathol Int"},{"key":"961_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1046\/j.1440-1746.2000.02157.x","volume":"15","author":"V Singh","year":"2000","unstructured":"Singh V, Sinha SK, Nain CK, Bambery P, Kaur U, Verma S, Chawla YK, Singh K: Budd-chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol. 2000, 15: 550-554. 10.1046\/j.1440-1746.2000.02157.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"961_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1148\/radiol.09090738","volume":"254","author":"D Gwon 2nd","year":"2010","unstructured":"Gwon D, Ko GY, Yoon HK, Sung KB, Kim JH, Lee SS, Lee JM, Ohm JY, Shin JH, Song HY: Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence, characteristics, and risk factors and clinical efficacy of TACE. Radiology. 2010, 254: 617-626. 10.1148\/radiol.09090738.","journal-title":"Radiology"},{"key":"961_CR10","first-page":"3237","volume":"46","author":"T Kawaguchi","year":"1999","unstructured":"Kawaguchi T, Sata M, Ono N, Sakisaka S, Koga H, Ijuin H, Mitsuyama K, Ueno T, Kage M, Tanikawa K: Budd-chiari syndrome complicated by hepatocellular carcinoma with no evidence of infection with hepatitis virus: a case report. Hepatogastroenterology. 1999, 46: 3237-3240.","journal-title":"Hepatogastroenterology"},{"key":"961_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J: Clinical management of hepatocellular carcinoma. Conclusions of the barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol. 2001, 35: 421-430. 10.1016\/S0168-8278(01)00130-1.","journal-title":"J Hepatol"},{"key":"961_CR12","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1053\/j.gastro.2004.09.023","volume":"127","author":"B Daniele","year":"2004","unstructured":"Daniele B, Bencivenga A, Megna AS, Tinessa V: Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology. 2004, 127: S108-S112. 10.1053\/j.gastro.2004.09.023.","journal-title":"Gastroenterology"},{"key":"961_CR13","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.20933","volume":"42","author":"J Bruix","year":"2005","unstructured":"Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology. 2005, 42: 1208-1236. 10.1002\/hep.20933.","journal-title":"Hepatology"},{"key":"961_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hep.21966","volume":"47","author":"A Forner","year":"2008","unstructured":"Forner A, Vilana R, Ayuso C, Bianchi L, Sole M, Ayuso JR, Boix L, Sala M, Varela M, Llovet JM, et al: Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008, 47: 97-104.","journal-title":"Hepatology"},{"key":"961_CR15","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1148\/radiographics.22.5.g02se191077","volume":"22","author":"KH Lee","year":"2002","unstructured":"Lee KH, Sung KB, Lee DY, Park SJ, Kim KW, Yu JS: Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein. Radiographics. 2002, 22: 1077-1091.","journal-title":"Radiographics"},{"key":"961_CR16","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","volume":"359","author":"JM Llovet","year":"2002","unstructured":"Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Sola R, et al: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002, 359: 1734-1739. 10.1016\/S0140-6736(02)08649-X.","journal-title":"Lancet"},{"key":"961_CR17","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","volume":"35","author":"CM Lo","year":"2002","unstructured":"Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002, 35: 1164-1171. 10.1053\/jhep.2002.33156.","journal-title":"Hepatology"},{"key":"961_CR18","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1136\/gut.2007.139477","volume":"57","author":"R Moucari","year":"2008","unstructured":"Moucari R, Rautou PE, Cazals-Hatem D, Geara A, Bureau C, Consigny Y, Francoz C, Denninger MH, Vilgrain V, Belghiti J, et al: Hepatocellular carcinoma in budd-chiari syndrome: characteristics and risk factors. Gut. 2008, 57: 828-835. 10.1136\/gut.2007.139477.","journal-title":"Gut"},{"key":"961_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1148\/radiology.210.2.r99fe13443","volume":"210","author":"V Vilgrain","year":"1999","unstructured":"Vilgrain V, Lewin M, Vons C, Denys A, Valla D, Flejou JF, Belghiti J, Menu Y: Hepatic nodules in budd-chiari syndrome: imaging features. Radiology. 1999, 210: 443-450.","journal-title":"Radiology"},{"key":"961_CR20","first-page":"704","volume":"87","author":"K Aoki","year":"1986","unstructured":"Aoki K, Miyamoto T, Murata H, Kawahara K, Oka Y, Maeda S, Yamashita K: Significance of accessory hepatic venography to evaluate the intrahepatic venous system for obstruction of the inferior vena cava at the hepatic portion with main hepatic vein obstruction. Nihon Geka Gakkai Zasshi. 1986, 87: 704-","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"961_CR21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0016-5085(82)90001-4","volume":"82","author":"IW Simson","year":"1982","unstructured":"Simson IW: Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in south africa. Gastroenterology. 1982, 82: 171-178.","journal-title":"Gastroenterology"},{"key":"961_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00005792-199401000-00003","volume":"73","author":"JB Dilawari","year":"1994","unstructured":"Dilawari JB, Bambery P, Chawla Y, Kaur U, Bhusnurmath SR, Malhotra HS, Sood GK, Mitra SK, Khanna SK, Walia BS: Hepatic outflow obstruction (budd-chiari syndrome). experience with 177 patients and a review of the literature. Medicine (Baltimore). 1994, 73: 21-36.","journal-title":"Medicine (Baltimore)"},{"key":"961_CR23","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich G, Stroffolini T, Zagni I, Donato F: Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004, 127: S35-S50. 10.1053\/j.gastro.2004.09.014.","journal-title":"Gastroenterology"},{"key":"961_CR24","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1111\/j.1440-1746.2004.03642.x","volume":"19","author":"D Valla","year":"2004","unstructured":"Valla D: Hepatic venous outflow tract obstruction etiopathogenesis: asia versus the west. J Gastroenterol Hepatol. 2004, 19: S204-S211. 10.1111\/j.1440-1746.2004.03642.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"961_CR25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1148\/radiographics.22.4.g02jl17847","volume":"22","author":"G Brancatelli","year":"2002","unstructured":"Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R: Benign regenerative nodules in budd-chiari syndrome and other vascular disorders of the liver: radiologic-pathologic and clinical correlation. Radiographics. 2002, 22: 847-862.","journal-title":"Radiographics"},{"key":"961_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1148\/radiology.210.1.r99ja1975","volume":"210","author":"CB Winston","year":"1999","unstructured":"Winston CB, Schwartz LH, Fong Y, Blumgart LH, Panicek DM: Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers. Radiology. 1999, 210: 75-79.","journal-title":"Radiology"},{"key":"961_CR27","doi-asserted-by":"publisher","first-page":"W168","DOI":"10.2214\/AJR.05.0168","volume":"188","author":"G Brancatelli","year":"2007","unstructured":"Brancatelli G, Vilgrain V, Federle MP, Hakime A, Lagalla R, Iannaccone R, Valla D: Budd-chiari syndrome: spectrum of imaging findings. AJR Am J Roentgenol. 2007, 188: W168-W176. 10.2214\/AJR.05.0168.","journal-title":"AJR Am J Roentgenol"},{"key":"961_CR28","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1001\/archsurg.1994.01420310070012","volume":"129","author":"MF Chen","year":"1994","unstructured":"Chen MF, Hwang TL, Jeng LB, Wang CS, Jan YY, Chen SC: Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg. 1994, 129: 738-742. 10.1001\/archsurg.1994.01420310070012.","journal-title":"Arch Surg"},{"key":"961_CR29","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1002\/lt.20034","volume":"10","author":"JM Llovet","year":"2004","unstructured":"Llovet JM, Fuster J, Bruix J: The barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004, 10: S115-S120. 10.1002\/lt.20034.","journal-title":"Liver Transpl"},{"key":"961_CR30","doi-asserted-by":"publisher","first-page":"S179","DOI":"10.1053\/j.gastro.2004.09.032","volume":"127","author":"J Bruix","year":"2004","unstructured":"Bruix J, Sala M, Llovet JM: Chemoembolization for hepatocellular carcinoma. Gastroenterology. 2004, 127: S179-S188. 10.1053\/j.gastro.2004.09.032.","journal-title":"Gastroenterology"},{"key":"961_CR31","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/sj.bjc.6602590","volume":"92","author":"TF Greten","year":"2005","unstructured":"Greten TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S, Klempnauer J, Galanski M, Manns MP: Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer. 2005, 92: 1862-1868. 10.1038\/sj.bjc.6602590.","journal-title":"Br J Cancer"},{"key":"961_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1053\/j.gastro.2006.05.021","volume":"131","author":"K Takayasu","year":"2006","unstructured":"Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, et al: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006, 131: 461-469. 10.1053\/j.gastro.2006.05.021.","journal-title":"Gastroenterology"},{"key":"961_CR33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1148\/radiology.195.3.7754005","volume":"195","author":"Y Hatanaka","year":"1995","unstructured":"Hatanaka Y, Yamashita Y, Takahashi M, Koga Y, Saito R, Nakashima K, Urata J, Miyao M: Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management. Radiology. 1995, 195: 747-752.","journal-title":"Radiology"},{"key":"961_CR34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/00004836-199906000-00010","volume":"28","author":"S Savastano","year":"1999","unstructured":"Savastano S, Miotto D, Casarrubea G, Teso S, Chiesura-Corona M, Feltrin GP: Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child\u2019s grade a or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol. 1999, 28: 334-340. 10.1097\/00004836-199906000-00010.","journal-title":"J Clin Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-13-105\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:23:04Z","timestamp":1630542184000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-13-105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,24]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["961"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-13-105","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,24]]},"assertion":[{"value":"10 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"105"}}